¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Alpha Lipoic Acid Oral"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
  • muramic acid
    ¹Â¶ó¹Í»ê
  • mycolic acid
    ¹ÌÄÝ»ê
  • malonic acid
    ¸»·Ð»ê
  • myristic acid
    ¹Ì¸®½ºÆ¾»ê
  • mandelic acid
    ¸¸µ¨»ê
  • methacrylic acid
    ¸ÞŸũ¸±»ê
  • methylhippuric acid
    ¸ÞÆ¿È÷Ǫ¸£»ê
  • N-acetylneuraminic acid
    N-¾Æ¼¼Æ¿´º¶ó¹Î»ê
  • neuraminic acid
    ´º¶ó¹Î»ê
  • neurostearic acid
    ½Å°æÁö¹æ»ê
  • nicotinic acid
    ´ÏÄÚÆ¾»ê
  • nitric acid
    Áú»ê
  • nitrobenzoic acid
    ´ÏÆ®·Îº¥Á¨»ê
  • nitrohydrochloric acid
    Áú¿°»ê, ¿Õ¼ö
  • nitrous acid
    ¾ÆÁú»ê
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
  • ribonucleic acid
    ¸®º¸ÇÙ»ê, ¾Ë¿£¿¡ÀÌ
  • saccharic acid
    »çÄ«¸°»ê
  • salicylic acid
    »ì¸®½Ç»ê
  • saturated acid
    Æ÷È­Áö¹æ»ê
  • sialic fatty acid
    ½Ã¾Ë»ê
  • spermanucleic acid
    Á¤ÀÚÇÙ»ê
  • succinic acid
    ¼÷½Å»ê
  • sugar acid
    ´ç»ê
  • sulfuric acid
    Ȳ»ê
  • tannic acid
    ź´Ñ»ê
  • tartaric acid
    Ÿ¸£Å¸¸£»ê
  • taurocholic acid
    Ÿ¿ì·ÎÄÝ»ê
  • teichoic acid
    Å×ÀÌÄÚ»ê
  • teichuronic acid
    Å×ÀÌÅ¥·Ð»ê
  • tricarboxylic acid
    »ïÄ«¸£º¹½Ç»ê
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
  • arormatic amino acid
    ¹æÇâÁ·¾Æ¹Ì³ë»ê
  • arsenic acid
    ºñ»ê(Ý÷ß«).
  • arsenoacetic acid
    ¾Æ¸£¼¼³ë¾Æ¼¼Æ®»ê.
  • arsenous acid
    ¾Æºñ»ê(ä¬Ý÷ß«).
  • free acid
    À¯¸®»ê(ë´ìÆß«).
  • free fatty acid
    À¯¸®Áö¹æ»ê.
  • free fatty acid.
    À¯¸®Áö¹æ»ê
  • fuming sulfuric acid
    ¹ß¿¬È²»ê(¡­üÜß«).
  • gastric acid
    À§»ê(ß«)
  • gastric acid secretion
    À§(êÖ)(¾×(äû))»êºÐºñ(ß«ÝÂÝô).
  • gastric acid secretory studies
    À§»êºÐºñ °Ë»ç.
  • general acid
    ÀϹݻê(ìéÚõß«).
  • glacial acetic acid
    ºùÃÊ»ê.
  • glucuronic acid
    ±Û·çÄí·Ð»ê.
  • glucuronic acid pathway
    ±Û·çÄí·Ð»ê°æ·Î.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
  • oral infection
    ±¸°­°¨¿°(Áõ)(Ϣ˷Êïæøñø).
  • oral inoculation
    °æ±¸Åõ¿©
  • oral insulin substitute
    °æ±¸(Àû) ´ë¿ë(ÌèÏ¢îÜÓÛéÄ)Àν¶¸°, °æ±¸(Àû) Àν¶¸° ´ë¿ë¾à(¡­ÓÛéÄå·).
  • oral insulin substitute
    °æ±¸(Àû) ´ë¿ë(ÌèÏ¢(îÜ) ÓÛéÄ)Àν¶¸°, °æ±¸(Àû) Àν¶¸° ´ë¿ë¾à(¡­ÓÛéÄå·).
  • oral intake
    °æ±¸(Àû) ¼·Ãë(ÌèÏ¢îÜàîö¢).
  • oral malignancy
    ±¸³»¾Ç¼ºÁ¾¾ç
  • oral malignancy
    ±¸³»¾Ç¼º Á¾¾ç(Ï¢Ò®ç÷àõðþÜ»).
  • oral manifestation
    ±¸°­Â¡ÈÄ
  • oral manifestation
    ±¸°­Â¡ÈÄ(Ϣ˷ó£ý¦).
  • oral medications
    °æ±¸Åõ¾à(ÌèÏ¢÷áå·).
  • oral medicine
    ±¸°­Ä¡·áÇÐ
  • oral medicine
    ±¸°­Ä¡·áÇÐ(Ϣ˷ö½èþùÊ).
  • oral microbial flora
    ±¸°­¹Ì»ý¹°ÃÑ(Ï¢Ë·Ú°ßæ Úªõ¿).
  • oral microbiology
    ±¸°­¹Ì»ý¹°ÇÐ.
  • oral microbiota
    ±¸°­¹Ì»ý¹°ÃÑ(Ï¢Ë·Ú°ßæÚªõ¿).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
  • imino acid
    À̹̳ë»ê(ß«)
  • indispensable amino acid
    ºÒ°¡°á(ÝÕʦÌÀ) ¾Æ¹Ì³ë»ê(ß«)
  • indoleacetic acid
    Àε¹¾Æ¼¼Æ®»ê(ß«)
  • infectious nucleic acid
    °¨¿°¼ºÇÙ»ê(Êïæøàõú·ß«)
  • inosinic acid
    À̳ë½Å»ê(ß«)
  • isoascorbic acid
    ¾ÆÀ̼ҾƽºÄÚ¸£ºó»ê
  • isocitric acid
    ¾ÆÀ̼һçÀÌÆ®¸£»ê(ß«)
  • iso fatty acid
    ¾ÆÀ̼ÒÁö¹æ»ê(ò·Û¸ß«)
  • isonicotinic acid hydrazide
    ¾ÆÀ̼ҴÏÄÚÆ¾»ê(ß«) ÇÏÀ̵å¶óÁöµå
  • ketogenic amino acid
    ÄÉÅæ»ý¼º(ßæà÷) ¾Æ¹Ì³ë»ê(ß«)
  • -ketoglutaric acid
    -ÄÉÅ䱸¸£Å¸¸£»ê(ß«)
  • lactic acid
    ¶ôÆ®»ê(ß«)
  • lactic acid fermentation
    ¶ôÆ®»ê(ß«)¹ßÈ¿(Û£ý£)
  • lauric acid
    ¶ó¿ì¸£»ê(ß«)
  • Lewis acid
    ·çÀ̽º»ê(ß«)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 13
OCA oculocutaneous albinism; olivopontocerebellar atrophy; oral contraceptive agent
OCC object-centered coordinate [method]; oral cholecystography
OCG omnicardiogram; oral cholecystogram
OCH oral contraceptive hormone
OCM oral contraceptive medication
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 13
5 alpha-DHT 5 alpha-dehydrotestosterone
5 alpha-DHP 5 alpha-dihydroprogesterone
5 alpha-R 5 alpha-reductase
6-keto-PGF1 alpha 6-keto-prostaglandin FI1 alpha
6KPGF1 alpha 6 keto-PGF1 alpha
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • J acid

    Á¦ÀÌ »ê
    ¿°·áÀÇ Áß°£Ã¼.
  • jalapinolic acid
    ¾â¶óÇdzî»ê
    ÀÌÆ÷¹Ì¾Æ¿¡¼­ ¾ò¾îÁö´Â ¹è´çüÀÇ ¼ººÐ.
  • ketonic acid
    ÄÉÅæ »ê
  • kinotannic acid
    Ű³ëź´Ñ»ê
  • laccainic acid
    ¶óÄ«ÀÎ »ê
    Àû°¥»öÀÇ °áÁ¤ »ê.
  • laccic acid
    ¶óÅ© »ê
    ¶óÅ© ¿°·á¿¡¼­ ¾ò´Â Àû°¥»öÀÇ °áÁ¤¹°.
  • lactic acid
    À¯»ê
    Ä«¸£º¹½Ã±â, ¼ö»ê±â, ¸ÞÆ¿±â, ¼ö¼ÒÀÇ ³× ¿øÀÚ´ÜÀÌ °áÇÕÇÑ ºñ´ëĪ ź¼Ò ¿øÀÚ¸¦ °¡Áö´Â À¯±âÈ­ÇÕ¹°. È÷µå·Ï½Ã ÇÁ·ÎÇǿ»ê, ¶ôÆ®»ê, À¯»êÀ̶ó°íµµ ÇÑ´Ù. 1780³â K.W. ¼Ð·¹¿¡ ÀÇÇØ »êÆÐÇÑ ¿ìÀ¯ ¼Ó¿¡¼­ ¹ß°ßµÇ¾úÀ¸¸ç µ¿½Ä¹°°è¿¡ ³Î¸® Á¸ÀçÇÑ´Ù. D, L, DLÇüÀÇ ±¤ÇÐ À̼ºÁúü°¡ ÀÖ´Ù. L-Á¥»êÀº ÇØ´ç °úÁ¤ÀÇ ÃÖÁ¾ »ê¹°·Î¼­ ÇÇ·çºê»êÀÇ È¯¿ø¿¡ ÀÇÇØ »ý¼ºµÈ´Ù. Á¶ÇؼºÀÌ °­ÇÑ ÁÖ»ó °áÁ¤À̸ç, ³ì´ÂÁ¡Àº 25¡­26 ¡ÉÀÌ´Ù. ±ÙÀ°, µ¿¹°Á¶Á÷ ¼Ó¿¡ Á¸ÀçÇÏ¸ç »ç¶÷ÀÇ Ç÷¾× ¼Ó¿¡´Â 100 m§¤´ç 5¡­20 mgÀÌ Á¸ÀçÇϸç, ½ÉÇÑ ¿îµ¿¿¡ ÀÇÇØ Áõ°¡ÇÑ´Ù. ¿îµ¿¿¡ ÀÇÇÑ ±ÙÀ°ÀÇ ÇǷδ ±Û¸®ÄÚ°ÕÀÇ ºÐÇØ¿¡ ÀÇÇÑ L-Á¥»êÀÇ ÃàÀû°ú °ü°è°¡ ÀÖ´Ù. ÈÞ½Ä ½Ã¿¡´Â ±× ÀϺΰ¡ »êÈ­ ºÐÇØµÇÁö¸¸ ´ëºÎºÐ ¿ø·¡ÀÇ ±Û¸®ÄÚ°ÕÀ¸·Î ÀçÇÕ¼ºµÈ´Ù. D-Á¥»êÀº µÎ²¨¿î ÆÇ»ó °áÁ¤À̸ç, ³ì´ÂÁ¡Àº 26¡­27 ¡ÉÀÌ´Ù. DL-Á¥»ê
  • lactic acid bacteria
    Á¥»ê ±Õ
    ±Û·çÄÚ¿À½º µî ´ç·ù¸¦ ºÐÇØÇÏ¿© Á¥»êÀ» »ý¼ºÇÏ´Â ¼¼±Õ. ¶ôÆ®»ê±Õ, À¯»ê ±ÕÀ̶ó°íµµ ÇÑ´Ù. Á¥»ê ¹ßÈ¿¿¡ ÀÇÇØ »ý¼ºµÇ´Â Á¥»ê¿¡ ÀÇÇØ¼­ º´¿ø ±Õ°ú À¯ÇØ ¼¼±ÕÀÇ »ýÀ°ÀÌ ÀúÁöµÇ´Â ¼ºÁúÀ» À¯Á¦Ç°
  • lactic acid bacterium
    ¶ôÆ® ±Õ
  • lactic acid formation
    À¯»ê Çü¼º
  • lactonic acid
    ¶ôÅæ »ê
    À¯´ç. ¾Æ¶óºñ¾Æ °í¹«. °¥¶ôÅ佺¸¦ »êÈ­ÇÔÀ¸·Î½á ¾ò¾îÁø´Ù.
  • lanopalmic acid : ¾ç¸ðÁö¿¡ µé¾î ÀÖ´Â 1¼ö»ê±â¼ºÀÇ Æ÷È­ Áö¹æ»ê.

    lanosterol

    ¶ó³ë½ºÅ×·Ñ
    ¾ç¸ðÁö¿¡ µé¾î ÀÖ´Â ½ºÅ×·ÑÀÇ ÀÏÁ¾.
  • larinolic acid
    ¶ó¸®³î »ê
  • linolic acid
    ¸®³î»ê
  • lymphocantric acid
    ¸²Æ÷Ä­Æ®¸£»ê
    Àӯļº ¹éÇ÷º´ ȯÀÚÀÇ ¿ä¿¡¼­ ÃßÃâµÈ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
alpha-l-iduronidase <enzyme> An enzyme that hydrolyzes terminal desulfated alpha-l-iduronic acid residues of dermatan sulfate and of heparan sulfate; a deficiency of this enzyme is associated with Hurler syndrome and Scheie syndrome.
(05 Mar 2000)
alpha-macroglobulins Glycoproteins with a molecular weight of approximately 620,000 to 680,000. Precipitation by electrophoresis is in the alpha region. They include alpha 1-macroglobulins and alpha 2-macroglobulins. These proteins exhibit trypsin-, chymotrypsin-, thrombin-, and plasmin-binding activity and function as hormonal transporters.
(12 Dec 1998)
alpha-mannosidase <enzyme> Catalyses hydrolysis of terminal, non-reducing alpha-d-mannose residues in alpha-d-mannosides
Registry number: EC 3.2.1.24
Synonym: alpha-d-mannoside mannohydrolase, alpha-d-mannosidase, neutral alpha-mannosidase, alpha mannosidase a, alpha mannosidase b, lysosomal alpha-mannosidase, laman
(26 Jun 1999)
alpha-methylacyl-CoA racemase <enzyme> Involved in catabolism of branched-chain fatty acids derived from isoprenoids; acts on pristanoyl-CoA and trihydroxycoprostanoyl-CoA, but not on 3-methyl branched-chain or linear-chain acyl coas; amino acid sequence has been determined; genbank u89905 (rat) and u89906 (mouse); also isolated from human liver
Registry number: EC 5.1.99.-
Synonym: meac CoA racemase
(26 Jun 1999)
alpha methyl dopa <drug> An antihypertensive drug, preferred in pregnant patients.
(18 Nov 1997)
alpha-methyltyrosine <chemical> An inhibitor of the enzyme tyrosine 3-monooxygenase, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with pheochromocytoma and decreases the frequency and severity of hypertensive attacks and related symptoms in most patients. (martindale, the extra pharmacopoeia, 30th ed)
Pharmacological action: enzyme inhibitors.
(12 Dec 1998)
alpha-msh <chemical> A 13-amino acid peptide derived from the anterior pituitary gland in man and from the pars intermedia in lower vertebrates. Its amino acid sequence is identical to the first 13 amino acids of acth. It influences the formation of deposition of melanin in the body and produces colour changes in the skin of amphibians, fishes and reptiles. It is secreted in humans only during foetal life and occasionally during pregnancy.
Chemical name: alpha-Melanotropin (pig)
(12 Dec 1998)
alpha mucase <chemical> Combination of mucopolysaccharidases and chymotrypsin
(26 Jun 1999)
alpha-N-acetyl-D-glucosaminidase <enzyme> Believed to be deficient in sanfilippo syndrome type b
Registry number: EC 3.2.1.50
Synonym: alpha-n-acetylglucosaminidase
(26 Jun 1999)
alpha-N-acetylgalactosaminidase <enzyme> An enzyme that hydrolyzes 2-acetamido-2-deoxy-alpha-d-galactosides to the alcohol and free 2-acetamido-2-deoxy-d-galactose. A deficiency of this enzyme will result in Schindler disease.
(05 Mar 2000)
alpha-N-acetylglucosaminidase <enzyme> An enzyme that hydrolyzes glycosides of N-acetylglucosamine producing the alcohol and N-acetylglucosamine. A deficiency of this enzyme results in mucopolysaccharidosis III B.
(05 Mar 2000)
alpha-naphthylthiourea 1-(1-Naphthyl)-2-thiourea;a derivative of thiourea; a highly toxic antithyroid agent, especially to small mammals, causing pulmonary oedema, fatty degeneration of the liver, and low body temperature; used as a rat poison.
Acronym: ANTU
(05 Mar 2000)
alpha-neoagarooligosaccharide hydrolase <enzyme> Hydrolyzes the alpha-1,3 linkage of neoagarooligosaccharides; from marine bacterium, vibrio sp.; mw 42 kD; amino acid sequence has been determined
Registry number: EC 3.2.1.-
Synonym: alpha-naos hydrolase
(26 Jun 1999)
alpha-oxidation A form of oxidation of fatty acids in which carbons are removed one at a time in the form of CO2; the alpha-carbon is first hydroxylated and then converted into a carbonyl; a deficiency of this pathway is associated with Refsum's disease.
(05 Mar 2000)
alpha particle <physics> A radioactive particle made up of two protons and two neutrons, these particles are created by the decay of a radioactive material or by nuclear bombardment, and they are the same as the nucleus of a helium-4 atom.
(09 Oct 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 13
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 13
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 13
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 13
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 13
ÅëÇÕ°Ë»ö ¿Ï·á